Cymabay Therapeutics Inc (NASDAQ:CBAY)

2.79
Delayed Data
As of Jun 24
 +0.20 / +7.72%
Today’s Change
1.67
Today|||52-Week Range
4.83
-17.46%
Year-to-Date
No recent news for Cymabay Therapeutics Inc.

Today’s Trading

Previous close2.59
Today’s open2.63
Day’s range2.34 - 2.80
Volume212,234
Average volume (3 months)641,716
Market cap$238.8M
Data as of 4:01pm ET, 06/24/2022

Growth & Valuation

Earnings growth (last year)-71.14%
Earnings growth (this year)+4.72%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.80

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...+7.17+4.42%
--FV Pharma Internatio...0.000.00%
----
NEUNNeuroGenesis Inc0.000.00%
Data as of 3:58pm ET, 06/17/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$90.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Newark, California

Forecasts